Voyager Therapeutics Presents New Data Demonstrating Novel Candidate Therapeutic Antibodies Reduced…
Novel passive antibodies bind to paired helical filamentous tau and inhibit propagation of pathological tau Vectorized antibody demonstrates durable CNS expression more than six months post-dose Research presented at the Alzheimer’s…